Led Surf Therapeutics' extended seed round ($6M total) for ultrasound neuromodulation biotech targeting immune diseases.
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform aimed at treating chronic inflammatory disorders by stimulating the cholinergic anti-inflammatory pathway to restore immune balance
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform aimed at treating chronic inflammatory disorders by stimulating the cholinergic anti-inflammatory pathway to restore immune balance.